Polycystic Ovary Syndrome
Conditions
Interventions
Western Medicine group:Ethinylestradiol Tablets (II)
Traditional Chinese Medicine group:Tiangui Formula
Integrated Traditional Chinese and Western Medicine Group:Ethinylestradiol Tablets (II)+Tiangui Formula
Sponsors
Obstetrics and Gynecology Hospital, Fudan University
Eligibility
Sex/Gender
Female
Age
13 Years to 40 Years
Inclusion criteria
Inclusion criteria: 1: Meets the diagnostic criteria for polycystic ovary syndrome 2: Age 13-40 3: Sign the informed consent form 4: Voluntarily and truthfully provide case information 5: Follow the required treatment and follow-up procedures.
Exclusion criteria
Exclusion criteria: 1: Other causes of hyperandrogenemia, such as late-onset congenital adrenal hyperplasia and Cushing syndrome The diagnosis involves tumors of the ovaries and adrenal glands that secrete androgens, as well as 21-hydroxylase deficiency atypical adrenal hyperplasia Hypertrophy, exogenous androgen application, etc 2: Hyperprolactinemia (=50 ng/ml), hypothalamic amenorrhea, thyroid dysfunction 3: Those with severe conditions such as cardiovascular and cerebrovascular diseases, liver and kidney diseases, and hematopoietic system disorders 4: Patients during pregnancy or lactation 5: Individuals allergic to the investigational drug 6: Currently participating in other clinical trials 7: In the past 3 months, the use of hormonal contraceptives or antidiabetic medications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| T;AMH;SHBG;androstenedione;menstrual condition;Ovulation status;BMI;waist-to-hip ratio; | — |
Secondary
| Measure | Time frame |
|---|---|
| FSH;LH;E2;FAI;Vitamin D;Glucose and lipid metabolism indicators;TNF-a;IL-6;IL-22;Body composition situation;Acanthosis nigricans;acne;hairy;Ultrasound shows ovarian condition; | — |
Countries
china
Contacts
Public Contacthua jiang, jianqin huang
Obstetrics and Gynecology Hospital, Fudan University
Outcome results
None listed